Differential Behavioral Tolerance to the δ-Opioid Agonist SNC80 ([(+)-4-[(αR)-α-[(2S,5R)-2,5-Dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley Rats
暂无分享,去创建一个
[1] E. Jutkiewicz,et al. Comparison of Peptidic and Nonpeptidic δ-Opioid Agonists on Guanosine 5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) Binding in Brain Slices from Sprague-Dawley Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.
[2] Michael Rickels,et al. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants , 1995, Psychopharmacology.
[3] J. Haffmans,et al. Differential epileptogenic potentials of selectiveμ andδ opiate receptor agonists , 1983, Journal of Neural Transmission.
[4] D. Selley,et al. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5 '-[ y-[ 35 S ] thiol-triphosphate binding ( opioid receptor / cannabinoid receptor / ' y-aminobutyric acid type B receptor ) , 2005 .
[5] E. Jutkiewicz,et al. δ-Opioid Agonists: Differential Efficacy and Potency of SNC80, Its 3-OH (SNC86) and 3-Desoxy (SNC162) Derivatives in Sprague-Dawley Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.
[6] S. Watson,et al. The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats , 2004, Neuropsychopharmacology.
[7] E. Jutkiewicz,et al. Comparison of peptidic and nonpeptidic delta-opioid agonists on [ 35 S ] GTP γ S binding in brain slices from Sprague-Dawley rats , 2004 .
[8] F. Cicirata,et al. Comparative effects of lesions to the ponto-cerebellar and olivo-cerebellar pathways on motor and spatial learning in the rat , 2003, Neuroscience.
[9] V. Hruby,et al. Agonist-specific down-regulation of the human δ-opioid receptor , 2003 .
[10] J. Pintar,et al. Comparison of Receptor Mechanisms and Efficacy Requirements for δ-Agonist-Induced Convulsive Activity and Antinociception in Mice , 2002, Journal of Pharmacology and Experimental Therapeutics.
[11] E. Jutkiewicz,et al. Convulsant activity of a non-peptidic δ-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats , 2002, Psychopharmacology.
[12] E. Jutkiewicz,et al. Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats , 2002, Neuropsychopharmacology.
[13] H. Kalant,et al. Effect of NMDA antagonists, an NMDA agonist, and serotonin depletion on acute tolerance to ethanol , 2002, Pharmacology Biochemistry and Behavior.
[14] T. Ullrich,et al. Delta opioid discrimination learning in the rat Assessment with the selective delta agonist SNC80 , 2002, Pharmacology Biochemistry and Behavior.
[15] E. Jutkiewicz,et al. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. , 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[16] K. Rice,et al. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. , 2001, The Journal of pharmacology and experimental therapeutics.
[17] N. Mello,et al. Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity. , 2001, The Journal of pharmacology and experimental therapeutics.
[18] H. Loh,et al. Deltorphin II-induced Rapid Desensitization of δ-Opioid Receptor Requires Both Phosphorylation and Internalization of the Receptor* , 2000, The Journal of Biological Chemistry.
[19] P. Clarke,et al. The effects of δ agonists on locomotor activity in habituated and non-habituated rats , 2000 .
[20] V. Hruby,et al. Differential down-regulation of the human δ-opioid receptor by SNC80 and [d-Pen2,d-Pen5]enkephalin , 2000 .
[21] M. Clark,et al. Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy. , 1998, The Journal of pharmacology and experimental therapeutics.
[22] N. Mello,et al. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. , 1998, The Journal of pharmacology and experimental therapeutics.
[23] G. Di Chiara,et al. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats , 1998, Behavioural pharmacology.
[24] K. Rice,et al. Convulsive Behavior of Nonpeptide δ-Opioid Ligands:Comparison of SNC80 and BW373U86 in Mice , 1998 .
[25] T. Reisine,et al. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells. , 1997, Molecular pharmacology.
[26] D. Selley,et al. Acute and Chronic Effects of Opioids on δ and μ Receptor Activation of G Proteins in NG108‐15 and SK‐N‐SH Cell Membranes , 1997 .
[27] J. Kamei,et al. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. , 1997, The Journal of pharmacology and experimental therapeutics.
[28] Guo-Min Zhao,et al. Effects of multiple intracerebroventricular injections of [d-Pen2,d-Pen5]enkephalin and [d-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain δ-opioid receptors , 1997, Brain Research.
[29] D. Selley,et al. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Woods,et al. BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys. , 1995, European journal of pharmacology.
[31] J. Woods,et al. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist. , 1995, The Journal of pharmacology and experimental therapeutics.
[32] Stanley J. Watson,et al. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications , 1995, Trends in Neurosciences.
[33] J. Woods,et al. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. , 1994, The Journal of pharmacology and experimental therapeutics.
[34] R. Wise,et al. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] G. Schoenbaum,et al. A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration. , 1993, The Journal of pharmacology and experimental therapeutics.
[36] H. Mosberg,et al. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. , 1993, The Journal of pharmacology and experimental therapeutics.
[37] H. Loh,et al. Autoradiographic evidence for decrease in binding of μ- and δ-opioid receptors after subchronic [D-Ala2,D-Leu5]enkephalin treatment in rats , 1993 .
[38] G. Nisticó,et al. Delta opioid receptors mediate seizures produced by intrahippocampal injection of ala-deltorphin in rats. , 1992, Functional neurology.
[39] J. E. Platt,et al. Chronic restraint stress elicits a positive antidepressant response on the forced swim test. , 1982, European journal of pharmacology.